Print Friendly Page
Protocol No. A081105
Principal Investigator Leal, Ticiana
Age Group Adult
Sponsor Type National
Title Randomized Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) (ALCHEMIST)
Objective The purpose of this study is to compare any good and bad effects patients may have when treated with the standard treatment against patients who are treated with the standard treatment plus erlotinib (an investigational drug). Patients in this research study have early stage non-small cell lung cancer that was surgically removed and may have been treated with chemotherapy and/or radiation. The tumor removed has a mutation of a gene called EGFR (Epidermal Growth Factor Receptor). We are trying to find out if this mutation could help us make decisions about which type of treatment is best for people with your type of cancer.
Treatment Erlotinib is an investigational drug and will be taken once a day.
Description This study has two study groups. You will be "randomized" into one of the study groups. Randomization means that you are put into a group by chance. A computer program will place you in one of the study groups. You will have an equal chance of being placed in either group. Group 1 will get the study drug called erlotinib. Group 2 will not receive erlotinib and will be followed by their doctor. Click here for more info
- Patients must be previously enrolled in study A151216 with the result of lung cancer harboring an EGRF exon 19 deletion or L858R mutation.
- Completely resected stage IB, II or IIIA non-squamous non small cell lung cancer with negative margins
Applicable Disease Sites Lung
Therapies Involved Cytotoxic Chemotherapy; Other
Drugs Involved Not Applicable; OSI - 774 (erlotinib); Tarceva (erlotinib); erlotinib; placebo
Participating Institutions Aspirus UW Cancer Center (formerly Riverview Hospital); Aspirus Wausau Hospital, Aspirus Regional Cancer Center; Johnson Creek, UW Cancer Center; Langlade Memorial Hospital, Aspirus Regional Cancer Ctr; Swedish American Hospital, Rockford ; UW Hospital and Clinics; UWCCC 1 South Park; VA Hospital, Madison, WI